This is a Demo Server. Data inside this system is only for test purpose.
 

Suppression of STAT5A increases chemotherapeutic sensitivity in imatinib-resistant and imatinib-sensitive K562 cells

Loading...
Publication Logo

Date

2010

Journal Title

Journal ISSN

Volume Title

Publisher

Taylor & Francis Ltd

Open Access Color

Bronze

Green Open Access

Yes

OpenAIRE Downloads

114

OpenAIRE Views

71

Publicly Funded

No
Impulse
Average
Influence
Average
Popularity
Average

Research Projects

Journal Issue

Abstract

STAT proteins are cytoplasmic transcription factors that are involved in the regulation of numerous cellular activities such as cell growth, differentiation, and survival. In this study, we aimed to identify the expression pattern of STAT genes in imatinib-sensitive and -resistant K562 cells, and further, to reveal the effects of STAT5A siRNA knockdown on cell growth and apoptosis induction. The XTT cell proliferation assay showed that both sensitive and resistant K562 cells were sensitized to imatinib upon transfection with STAT5A siRNA. Caspase-3 enzyme activity was increased significantly in both cells. These results may open up new opportunities to overcome chemotherapeutic resistance in leukemia.

Description

Kosova, Buket/0000-0003-3636-6082; tezcanlı kaymaz, burçin/0000-0003-1832-1454; Ekiz, Huseyin Atakan/0000-0001-7718-6841; Yandim, Melis Kartal/0000-0003-0573-4276; Kartal Yandim, Melis/0000-0003-0573-4276; Baran, Yusuf/0000-0002-1056-4673

Keywords

Chronic myeloid leukemia (CML), chemotherapeutic resistance, reversal of resistance, imatinib, STAT5A, siRNA knockdown, STAT3 Transcription Factor, Cell Survival, Antineoplastic Agents, Apoptosis, Piperazines, Reversal of resistance, STAT5 Transcription Factor, Humans, Cell Proliferation, Dose-Response Relationship, Drug, Caspase 3, Gene Expression Regulation, Leukemic, Reverse Transcriptase Polymerase Chain Reaction, Gene Expression Profiling, Tumor Suppressor Proteins, Chronic myeloid leukemia, Small interfering RNA, Enzyme Activation, Pyrimidines, Drug Resistance, Neoplasm, Benzamides, Imatinib Mesylate, RNA Interference, Gene expression, K562 Cells

Fields of Science

0301 basic medicine, 03 medical and health sciences, 030304 developmental biology, 0303 health sciences

Citation

19

WoS Q

Q3

Scopus Q

Q3
OpenCitations Logo
OpenCitations Citation Count
18

Source

Leukemia & Lymphoma

Volume

51

Issue

10

Start Page

End Page

Collections

PlumX Metrics
Citations

CrossRef : 14

Scopus : 16

PubMed : 9

Captures

Mendeley Readers : 19

Google Scholar Logo
Google Scholar™

Sustainable Development Goals